Found 25 clinical trials
Multispectral Imaging Endoscopy in Digestive Inflammation
stomach or rectum and normal mucosa; the presence of glandular atrophy in stomach or intestinal metaplasia. The secondary objectives are: to identify reflectance
- 0 views
- 18 Feb, 2021
- 1 location
The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia
endoscopic follow up, patients will be prospectively tracked for up to 3 years. The investigators will also evaluate: The risk of progression to dysplasia or oesophageal intestinal
- 0 views
- 26 Jan, 2021
- 1 location
Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus
Barrett's oesophagus is a transformation of the esophageal mucous membrane there intestinal metaplasia under the effect of gastro- esophageal reflux disease (GERD). This metaplasia can
- 31 views
- 15 May, 2021
- 1 location
The Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System
The purpose of this study is to valuation of the diagnostic ability of white light imaging and magnifying endoscopy with optical enhancement system in early gastric cancer and intraepithelial neoplasia.
- 0 views
- 26 Jan, 2021
- 1 location
Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis
Treatment of H.pylori may not be achieved in many patients with chronic gastritis. Termination of the inflammatory respose produced by h.pylori may be useful in management of difficult cases. Heparanase is a pro-inflammatory mediator. Blocking of heparanase may relief the symptoms of chronic gastritis.
- 0 views
- 20 Oct, 2021
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
Introduction: Gastric atrophy and intestinal metaplasia are the principal precursors for gastric cancer and, therefore, are considered gastric premalignant conditions. Although current
- 0 views
- 19 Feb, 2021
- 1 location
Predict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia
Researchers are trying to see if the Nvision Imaging System (VLE) can accurately determine the risk of recurrent Barrett's esophagus in patients with Barrett's esophagus which have been clear of disease.
- 0 views
- 15 Feb, 2021
- 1 location
RFA for GIM Treatment
Use radiofrequency ablation (RFA) for Gastric intestinal metaplasia (GIM) treatment.
- 0 views
- 26 Feb, 2021
- 1 location
AI in GIM Diagnosis
This study will use artificial intelligence (AI) for diagnosing gastric intestinal metaplasia.
- 0 views
- 27 Feb, 2021
- 1 location
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
dysplasia or intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's Esophagus (BE) after 2 RFA treatments
- 22 views
- 21 Jan, 2022
- 8 locations